Ari Krayzman

Ari Krayzman is a Consultant at EVERSANA, focusing on NAVLIN Global Pricing & Market Access since November 2024. Prior experience includes roles as a Senior Analyst at The Dedham Group, specializing in Oncology & Specialty Therapeutics US Market Access from 2023 to 2024, and as an Associate Consultant at SciVida in 2022. In 2021, Ari served as a Clinical Services Strategy Intern at Aetna, a CVS Health Company, as part of the CVS Health General Management Development Program (GMDP). Earlier experience includes an internship in Market Access at eMAX Health Systems, LLC in 2020. Ari holds a Bachelor of Arts in Economics from the University of North Carolina at Chapel Hill and is associated with the UNC Shuford Program in Entrepreneurship.